Morpholine

Morpholine

SCHEMBL7989434

C1COCCN1.CCOc1ccc(C(=O)Cl)cc1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
FKBP1A P62942 1/20 0.48
PARP10 Q53GL7 1/20 0.47
CACNA1B Q00975 1/20 0.46
APBA1 Q02410 1/20 0.46
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46
NPC1 O15118 1/20 0.45
PLK1 P53350 1/20 0.45
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HSD17B10 Q99714 1/20 0.43
PLA2G4B P0C869 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
JAK2 O60674 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL7989270 0.87 PLA2G4B (0.59) HPGDALDH1A1LMNAMAPTFKBP1A
Morpholine SCHEMBL7988982 0.84 RAB9A (0.46) HPGDALDH1A1LMNAMAPTNPC1
SCHEMBL275646 0.83 PARP10 (0.66) HPGDALDH1A1PARP10NPC1PLK1
1,4-Diethoxybenzene SCHEMBL10980721 0.81 NQO1 (0.52) HPGDALDH1A1LMNAMAPTFKBP1A
SCHEMBL6642345 0.78 PARP10 (0.59) HPGDALDH1A1PARP10NPC1PLK1
Morpholine SCHEMBL16244866 0.77 FKBP1A (0.43) HPGDALDH1A1LMNAMAPTFKBP1A
SCHEMBL7721896 0.75 TP53 (0.58) HPGDALDH1A1PARP10NPC1PLK1
1,4-Diethoxybenzene SCHEMBL6015232 0.75 NQO1 (0.44) HPGDALDH1A1LMNAMAPTFKBP1A
Morpholine SCHEMBL7985369 0.74 NR1H4 (0.56) HPGDALDH1A1LMNAMAPTNPC1
Morpholine SCHEMBL27324712 0.72 FKBP1A (0.41) HPGDALDH1A1LMNAMAPTFKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed